BioHealth News Archive

Horizon Therapeutics plc Announces Phase 2 Trial Evaluating Dazodalibep for the Treatment of Sjögren’s Syndrome Meets Primary Endpoint

Horizon Therapeutics plc Announces Phase 2 Trial Evaluating Dazodalibep for the Treatment of Sjögren’s Syndrome Meets Primary Endpoint

- The Company plans to work with the FDA to design a Phase 3 program in moderate-to-high systemic disease activity patients to begin in 2023, ahead…

Read More
Biden Spurs U.S. Biotechnology with New Order – Nextgov

Biden Spurs U.S. Biotechnology with New Order – Nextgov

The Biden administration announced the launch of a new national program dedicated to fortifying America’s biotechnology manufacturing industry in the latest executive effort to…

Read More
Qiagen joins monkeypox test-making efforts

Qiagen joins monkeypox test-making efforts

As the number of monkeypox cases around the world has ballooned since early May, so too has the list of diagnostic developers rapidly churning…

Read More
Alexandria Real Estate Equities, Inc. Recognizes Important Milestones in Its Pioneering of New York City’s Commercial Life Science Cluster, the Only Early-Stage Life Science Ecosystem Among the Major Life Science Clusters in the United States

Alexandria Real Estate Equities, Inc. Recognizes Important Milestones in Its Pioneering of New York City’s Commercial Life Science Cluster, the Only Early-Stage Life Science Ecosystem Among the Major Life Science Clusters in the United States

NEW YORK, Sept. 12, 2022 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. ( NYSE: ARE), the first, longest-tenured and pioneering owner, operator and developer uniquely…

Read More
Finalists Selected For 7th Annual BioHealth Capital Region Crab Trap Competition

Finalists Selected For 7th Annual BioHealth Capital Region Crab Trap Competition

– Winner to be announced as part 2022 BioHealth Capital Region Forum – ROCKVILLE, MARYLAND, September 12, 2022 – A panel of investor judges…

Read More
PRESS RELEASE: Gradian Health Systems Announces Partnership with Canon Virginia Inc. (CVI) – Gradian Health Systems

PRESS RELEASE: Gradian Health Systems Announces Partnership with Canon Virginia Inc. (CVI) – Gradian Health Systems

New York, NY, September 6, 2022 | Gradian Health Systems (Gradian) is proud to announce a strategic relationship with Canon Virginia Inc. (CVI). This…

Read More

Former government scientist appointed first leader of ARPA-H – STAT

President Joe Biden plans to appoint longtime biologist and former government scientist Renee Wegrzyn as the first director of the nascent Advanced Research Projects…

Read More
Deka Biosciences Appoints Chief Medical Officer and Vice President of Clinical Operations

Deka Biosciences Appoints Chief Medical Officer and Vice President of Clinical Operations

GERMANTOWN, Md., Sept. 8, 2022 /PRNewswire/ -- Deka Biosciences ("Deka"), a biotech company focused on the development of novel cytokine therapies to treat cancer…

Read More
United Therapeutics subsidiary orders up to 1,000 drones for organ delivery | Fierce Biotech

United Therapeutics subsidiary orders up to 1,000 drones for organ delivery | Fierce Biotech

A subsidiary of United Therapeutics ($UTHR) has placed an order for up to 1,000 unmanned aerial vehicles (UAVs) from Chinese manufacturer EHang. The plan…

Read More
NIH seeks the next generation of COVID-19 diagnostics

NIH seeks the next generation of COVID-19 diagnostics

The National Institutes of Health has issued two new funding opportunities for diagnostic test manufacturers to develop the next generation of COVID-19 tests, with…

Read More
Adaptive Phage Therapeutics Announces “The AMR RAPID™ Challenge” for the Infectious Disease Research Community: Find a Bacteria Resistant to APT’s Investigational Phage Bank

Adaptive Phage Therapeutics Announces “The AMR RAPID™ Challenge” for the Infectious Disease Research Community: Find a Bacteria Resistant to APT’s Investigational Phage Bank

September 07, 2022 08:00 AM Eastern Daylight Time GAITHERSBURG, Md.--(BUSINESS WIRE)--Adaptive Phage Therapeutics, Inc. (“APT”), a clinical-stage biotechnology company controlling the world’s largest therapeutic…

Read More
Selexis and NexImmune Sign Service Agreement to Advance Multiple Immunotherapies Targeting Rare Cancers and Autoimmune Disorders

Selexis and NexImmune Sign Service Agreement to Advance Multiple Immunotherapies Targeting Rare Cancers and Autoimmune Disorders

Agreement supports the development of molecules targeting acute myeloid leukemia, multiple myeloma, human papilloma virus (HPV) associated tumors, and additional human leukocyte antigens (HLAs)…

Read More
Johns Hopkins Technology Ventures | View Our FY22 Annual Report

Johns Hopkins Technology Ventures | View Our FY22 Annual Report

I'm pleased to share with you JHTV's annual report for Fiscal Year 2022. As we returned to the office last year and The Johns…

Read More
MIMETAS appoints Dhaval Patel as Chair of the Board of Directors

MIMETAS appoints Dhaval Patel as Chair of the Board of Directors

LEIDEN, September 8, 2022 - MIMETAS, a global leader in organ-on-chip-based disease models for drug discovery and development, has appointed Dhaval Patel as Chair…

Read More
Jeeva is ranked among 61 Most Promising Clinical Trials Startups with Seed Funding (United States)

Jeeva is ranked among 61 Most Promising Clinical Trials Startups with Seed Funding (United States)

Just Funded selected the organizations listed in this article based on: Track record Executive leadership Market share Innovation ESG rating Shannon Wolfson from BlueCloudTV…

Read More